Specialty Enzymes
Naturally Independent Expo

Click Here for the Latest Episode of the Vitamin Professor Podcast Hosted by Gene Bruno

Bifidobacterium, bacterial strain3d illustration.

DuPont Human Microbiome Venture and Procter & Gamble Enter Research Collaboration

by Shari Barbanel | September 23, 2020

The DuPont Human Microbiome Venture (Copenhagen, Denmark) has announced a research partnership with The Procter & Gamble Company (P&G, Cincinnati, OH), focusing on the discovery and development of innovative next generation probiotics (NGPs) for human health.

Over the past years, both P&G and DuPont have conducted extensive research on human commensals to help address metabolic health issues in humans. In order to accelerate the development and commercialization of NGPs, both companies are joining forces to develop NGPs, initially to be used in dietary supplements.

There is an increasing number of studies that have shown that diet and poor lifestyle choices negatively affect the gut microbiota which can result in chronic low-grade inflammation which is closely associated with the onset and prevalence of metabolic health related conditions. On the contrary, increasing levels of certain anaerobic bacteria in the gut has been shown to increase insulin sensitivity and thus helps to maintain healthy blood sugar levels.

“It’s an exciting opportunity to partner with P&G to jointly develop the next generation of microbe-based products. The combination of DuPont’s and P&G’s unique set of capabilities will allow us to accelerate innovation in the field of metabolic health and help millions of consumers affected by metabolic health issues,” said Sebastien Guery, Human Microbiome Venture leader, DuPont Nutrition & Biosciences.

“As a company focused on innovation, P&G is excited to come together with our valued partners at DuPont. Many consumers trust Align, the No. 1 doctor and gastroenterologist recommended probiotic brand, to promote and support a healthy digestive system.* This strategic partnership will help us further advance our probiotic innovation via a next generation solution that will prove beneficial to the health and well-being of consumers around the world,” said Paul Gama, president, P&G Personal Health Care.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. 

For more information, visit www.pg.com, www.dupontnutritionandbiosciences.com or www.dupont.com.

 

Don't Miss Out!

Sign up for Nutrition Industry Executive Digital Newsletter
Digital Newsletter
Subscribe to Nutrition Industry Executive Magazine
Nutrition Industry Executive Magazine

Industry Professionals
Stay Informed!

Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Nutrition Industry Executive magazine and digital newsletter.

Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.

Featured Listings:


CapsCanada

Subscribe To Our Newsletter

Stay Informed! Breaking news, industry trends featured topics, and more.

Subscribe to our newsletter today!